News
Strata Skin Sciences
SSKN · NASDAQ
$0.00+$0.0001 (−100.00%)TodayMarket closed ·
No price history for this range.
Latest news
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Fastly Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico
- Press releaseGlobe Newswire
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
- News
Earnings Scheduled For November 13, 2025
- Press releaseGlobe Newswire
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
- Press releaseGlobe Newswire
STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update
- NewsAvi Kapoor
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
- NewsMohd Haider
STRATA Skin Sciences Rises 25% Pre-Market — Here's Why
- News
STRATA Skin Sciences' TheraClearX Treatment For Acne Gets Regulatory Approval From Mexico's Health Authority Through November 2029
- Press releaseGlobe Newswire
STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements
- Press releaseGlobe Newswire
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
- Press releaseGlobe Newswire
Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Dow Jumps 250 Points; AutoZone Posts Downbeat Earnings
- News
Preview: Strata Skin Sciences's Earnings
- News
A Peek at Strata Skin Sciences's Future Earnings
- News
What to Expect from Strata Skin Sciences's Earnings
- Press releaseGlobe Newswire
STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.